BRVE — Braveheart Bio, Inc. | Earnings, Ratings & Filings — BullishAgent

BullishAgent EDGAR Earnings Ratings Insiders Shorts ETFs Screener

Sign in Register

BRVE

Braveheart Bio, Inc.

$27.03

+4.08% vs $25.97

Mkt Cap $1.9B

52w Low $24.61 32.7% of range 52w High $32.00

50d MA $27.41 200d MA $27.41

P/E (TTM) —

EV/EBITDA —

P/B —

Debt/Equity —

ROE —

P/FCF —

RSI (14) 73.30

ATR (14) $2.40

Beta —

50d MA $27.41

200d MA $27.41

Avg Volume —

CIK (SEC)

2131524

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
Aug 7, 2026	ORBIMED ADVISORS LLCDir	—	Buy	273,333	$18.00	$4.9M	273,333	+4.56%	—
Aug 7, 2026	ORBIMED ADVISORS LLCDir	—	Buy	1,666,667	$18.00	$30.0M	11,901,826	+4.56%	—
Aug 7, 2026	Chimovits ErezDir	—	Buy	273,333	$18.00	$4.9M	273,333	+4.56%	—
Aug 7, 2026	Chimovits ErezDir	—	Buy	1,666,667	$18.00	$30.0M	11,901,826	+4.56%	—
Aug 7, 2026	AH Bio Fund IV, L.P.	—	Buy	1,100,000	$18.00	$19.8M	10,232,420	+4.56%	—

· Source: financialmodelingprep.com